David T Doherty sold $202k of SGRY
Chief Financial Officer at Surgery Partners, Inc.. 14,574 shares at an average of $13.84, traded Mar 6, 2026, filed Mar 9, 2026.
Score components
- +22RoleCFO
- +12Trade size$202k at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.9%, 3m +4.2%, 6m +7.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001638833-26-000023, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | SOpen-market sale Common Stock | -14,574 | $13.84 | $202k | 88,803 | Mar 9, 2026 |
| Mar 5, 2026 | AGrant or award Common Stock | +56,697 | $14.11 | $800k | 145,500 | Mar 9, 2026 |
| Mar 5, 2026 | AGrant or award Common Stock | +54,545 | $14.11 | $770k | 200,045 | Mar 9, 2026 |
| Mar 5, 2026 | AGrant or award Common Stock | +30,501 | $14.11 | $430k | 230,546 | Mar 9, 2026 |
Related signals
Other insiders at Surgery Partners, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | SGRYbuy Surgery Partners, Inc. | Teresa DeLuca director | $161k 11,250 shares | +20% | |
| 37Weak | SGRYbuy Surgery Partners, Inc. | Teresa DeLuca director | $144k 10,000 shares | +18% | |
| 38Weak | Surgery Partners, Inc. | Jennifer Baldock Chief Admin & Dev Officer | $76k 5,798 shares | -2% | |
| 36Weak | Surgery Partners, Inc. | Marissa Brittenham Chief Strategy Officer | $46k 3,657 shares | -4% | |
| 36Weak | Surgery Partners, Inc. | Danielle Burkhalter Chief Human Resources Officer | $45k 3,469 shares | -4% | |
| 47Moderate | Surgery Partners, Inc. | David T Doherty Chief Financial Officer | $111k 8,867 shares | -4% | |
| 53Moderate | Surgery Partners, Inc. | Jason Eric Evans Chief Executive Officer | $254k 20,400 shares | -2% | |
| 41Moderate | Surgery Partners, Inc. | Jennifer Baldock Chief Admin & Dev Officer | $138k 10,082 shares | -3% | |
| 45Moderate | Surgery Partners, Inc. | Marissa Brittenham Chief Strategy Officer | $120k 8,785 shares | -14% | |
| 45Moderate | Surgery Partners, Inc. | Danielle Burkhalter Chief Human Resources Officer | $105k 7,736 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.